Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Jun 27, 2023; 15(6): 1116-1124
Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1116
Published online Jun 27, 2023. doi: 10.4240/wjgs.v15.i6.1116
Table 1 Basic demographics in both groups, n (%)
| Group A (n = 90) | Group B (n = 162) | P value | |
| Gender | |||
| Female | 57 (36.3) | 100 (63.7) | |
| Male | 33 (34.7) | 62 (65.3) | 0.80 |
| Comorbidities | 85 (36.2) | 150 (63.8) | |
| No comorbidities | 5 (29.4) | 12 (70.6) | 0.57 |
| No of previous abdominal surgery (mean ± SD) | 1.92 ± 1.18 | 2.12 ± 1.44 | 0.28 |
| Age (yr), mean ± SD | 68.89 ± 17.37 | 68.13 ± 15.56 | 0.72 |
Table 2 Symptoms on presentation in both groups, n (%)
| Group A (n = 90) | Group B (n = 162) | P value | |
| Nausea | 56 (35.7) | 101 (64.3) | |
| No nausea | 9 (37.5) | 15 (62.5) | 0.76 |
| Vomiting | 63 (34.2) | 121 (65.8) | |
| No vomiting | 27 (39.7) | 41 (60.3) | 0.42 |
| Abdominal pain | 83 (35.3) | 152 (64.7) | |
| No pain | 7 (41.2) | 10 (58.8) | 0.63 |
| Abdominal distension | 37 (37.0) | 63 (63.0) | |
| No distension | 50 (33.8) | 98 (66.2) | 0.22 |
| Flatus | 37 (38.5) | 59 (61.5) | |
| No flatus | 53 (34.0) | 103 (66.0) | 0.56 |
| No obstipation | 37 (31.9) | 79 (68.1) | |
| Obstipation | 53 (39.0) | 83 (61.0) | 0.24 |
Table 3 Physiological and laboratory parameters on arrival in both groups
| Group A (mean ± SD) | Group B (mean ± SD) | P value | |
| Heart rate (beat/min) | 81.20 ± 15.67 | 82.89 ± 16.74 | 0.474 |
| Systolic blood pressure (mmHg) | 142.51 ± 26.97 | 146.79 ± 28.09 | 0.285 |
| Diastolic blood pressure (mmHg) | 69.65 ± 22.08 | 69.67 ± 20.17 | 0.994 |
| Respiratory rate (/min) | 20.15 ± 10.29 | 19.50 ± 3.68 | 0.559 |
| Temperature (ºC) | 36.56 ± 0.77 | 36.52 ± 0.72 | 0.697 |
| White cell count (× 109/L) | 12.27 ± 3.86 | 11.89 ± 3.96 | 0.495 |
| C-reactive protein (mg/L) | 24.96 ± 60.88 | 21.81 ± 45.25 | 0.691 |
| Urea (mmol/L) | 8.77 ± 6.81 | 9.40 ± 6.59 | 0.606 |
| Creatinine (umol/L) | 103.75 ± 55.35 | 110.00 ± 131.23 | 0.660 |
| Lactate (mmol/L) | 2.110 ± 0.97 | 1.942 ± 1.23 | 0.522 |
Table 4 The findings of computed tomography scan on presentation and abdominal X-ray following administration of water-soluble contrast medium in both groups, n (%)
| Group A (n = 90) | Group B (n = 162) | OR (95%CI) | P value | |
| Definitive transition point | 85 (94.4) | 140 (86.4) | 2.67 (0.975-7.318) | 0.048 |
| No transition point | 5 (5.6) | 22 (13.6) | ||
| Mesenteric stranding | 64 (71.1) | 96 (59.3) | 1.69 (0.973-2.942) | 0.061 |
| No mesenteric stranding | 26 (28.9) | 66 (40.7) | ||
| Small bowel thickening | 12 (13.3) | 13 (8.0) | 1.76 (0.768-4.084) | 0.177 |
| No small bowel thickening | 78 (86.7) | 149 (92) | ||
| Water-soluble contrast medium | 42 (46.7) | 98 (60.5) | 0.55 (0.323-0.936) | 0.024 |
| Did not receive water-soluble contrast medium | 47 (53.3) | 60 (39.5) | ||
| Presence of free fluid | 72 (80) | 106 (65.4) | 2.11 (1.149-3.888) | 0.015 |
| No free fluid | 18 (20) | 56 (34.6) | ||
| No small bowel faecal sign | 42 (46.7) | 55 (34.0) | 1.70 (1.005-2.882) | 0.047 |
| Small bowel faecal sign present | 48 (53.3) | 107 (66.0) | ||
| Contrast reaches small bowel only | 23 (25.6) | 34 (21.0) | 3.83 (1.790- 8.209)1 | 0.001 |
| Contrast reach large bowel | 19 (74.4) | 76 (79.0) | ||
| Grade of obstruction (proximal small bowel diameter in mm), mean ± SD | 36.87 ± 7.53 | 37.35 ± 6.77 | 0.601 |
- Citation: Ng ZQ, Hsu V, Tee WWH, Tan JH, Wijesuriya R. Predictors for success of non-operative management of adhesive small bowel obstruction. World J Gastrointest Surg 2023; 15(6): 1116-1124
- URL: https://www.wjgnet.com/1948-9366/full/v15/i6/1116.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i6.1116
